2014/514/EU: Commission Implementing Decision of 31 July 2014 authorising laboratories in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2014) 5352) Text with EEA relevance
Text
Article-level text, parsed from the formex manifestation.
Article 1
In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets: (a) KBNP, INC 235-9, Chusa-ro, Sinam-myeon Yesan-gun, Chungcheongnam-do Republic of Korea (b) Komipharm International Co. Ltd 17 Gyeongje-ro, Siheung-si, Gyeonggi-do, 429-848 Republic of Korea
Article 2
This Decision shall apply from 15 August 2014.
Article 3
This Decision is addressed to the Member States.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions